ProsTIC in the news

World leading research in the news:

UroToday: The TheraP Trial video interview   

See this interview with Prof Matthew Cooperberg

Prostatepedia Magazine: Theranostics issue 

See this interview with Prof. Michael Hofman (pages 8-11).

3-year update from the TheraP trial

See this article published in ASCO daily news: Lu-177 Vipivotide Tetraxetan Yields Similar OS Versus Cabazitaxel in mCRPC Progressing After Docetaxel

Aussie researchers begin ‘world-first’ clinical trial

See this article on the EVOLUTION Phase II  clinical trial to evaluate the effectiveness of experimental therapy combined with immunotherapy in patients with prostate cancer.

New technique to diagnose prostate cancer

See video and article how prostate cancer experts have revealed they can improve diagnosis through sophisticated imaging techniques instead of invasive biopsies.


Advanced Prostate Cancer Consensus Conference (APCCC) 2022

Dr Renu Eapen presents "Best of Surgical Journals" @ ASCO GU 22

ASCO GU22 | Imaging Biomarkers analysis from the TheraP trial

#EANM21 - Prostate Cancer Along the Yellow Brick Road

Plenary | Role of PSMA PET/CT for de novo vs recurrent disease

TheraP ASCO GU presentation

TheraP data further support LuPSMA for mCRPC 

Prof Michael Hofman talks to Nine News 

House of Wellness Program - Channel 7 


Professor Michael Hofman features in this fascinating discussion on ABC Nighlife's Audit on Cancer (from 32:43). The program explores advances in cancer detection and treatment in Australia and across the globe.

Listen to Professor Michael Hofman being interviewed on The Chris Smith Show - 2GB.

World-first prostate cancer treatment trialled - Nine News Australia

Molecular imaging could transform management of people with aggressive cancer - Peter Mac News

Prostate Cancer's New Standard of Care - Australian Financial Review

Movember Story - Prostate cancer study could transform management of patients with aggressive cancer